Endo Health buys migraine patch-maker for $105M

12/17/2013 | Reuters

Endo Health Solutions agreed to pay about $105 million to acquire NuPathe and its lead product Zecuity, the only FDA-approved prescription patch for migraine. The acquisition could be finalized early next year, and Endo plans to commercialize the migraine patch in the first half of 2014.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY